A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

NCT04590235 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurofibromatosis 1
Neurofibroma Plexiform

Interventions

DRUG: Selumetinib

Sponsor

AstraZeneca

Collaborators

[object Object]